According to HCA Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 15.5505. At the end of 2022 the company had a P/E ratio of 12.2.
Year | P/E ratio | Change |
---|---|---|
2022 | 12.2 | 3.23% |
2021 | 11.8 | -20.16% |
2020 | 14.8 | 3.21% |
2019 | 14.4 | 26.17% |
2018 | 11.4 | -20.32% |
2017 | 14.3 | 47.16% |
2016 | 9.71 | -25.63% |
2015 | 13.1 | -22.59% |
2014 | 16.9 | 23.7% |
2013 | 13.6 | 64.84% |
2012 | 8.27 | 94.57% |
2011 | 4.25 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Universal Health Services
UHS | 18.6 | 19.64% | ๐บ๐ธ USA |
Community Health Systems
CYH | 2.03 | -86.96% | ๐บ๐ธ USA |
Tenet Healthcare THC | 27.9 | 79.62% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.